ArticleCureus2026

Efficacy and Safety of Tofacitinib Compared to Cyclophosphamide in Early Diffuse Cutaneous Systemic Sclerosis: A Randomized Controlled Trial.

Nabil Amin Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.